These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 17641019)

  • 1. Listeriolysin O expressed in a bacterial vaccine suppresses CD4+CD25high regulatory T cell function in vivo.
    Nitcheu-Tefit J; Dai MS; Critchley-Thorne RJ; Ramirez-Jimenez F; Xu M; Conchon S; Ferry N; Stauss HJ; Vassaux G
    J Immunol; 2007 Aug; 179(3):1532-41. PubMed ID: 17641019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Treg suppression by a listeriolysin-O-expressing E. coli vaccine in heterologous prime-boost vaccination against cancer.
    Dai MS; Vassaux G; Xu M; You RI; Hsieh YF; Ouisse LH; Lo KY; Sytwu HK; Chao TY
    Vaccine; 2012 Nov; 30(48):6903-11. PubMed ID: 22982404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant E. coli LLO/OVA induces murine BMDCs maturation via TLR4 and NOD1 receptor and promotes specific cytotoxic T cell immunity.
    Xu M; Dai MS
    Biomed Environ Sci; 2010 Oct; 23(5):350-6. PubMed ID: 21112482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Listeriolysin O-liposome-mediated cytosolic delivery of macromolecule antigen in vivo: enhancement of antigen-specific cytotoxic T lymphocyte frequency, activity, and tumor protection.
    Mandal M; Lee KD
    Biochim Biophys Acta; 2002 Jun; 1563(1-2):7-17. PubMed ID: 12007619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A recombinant E. coli vaccine to promote MHC class I-dependent antigen presentation: application to cancer immunotherapy.
    Radford KJ; Higgins DE; Pasquini S; Cheadle EJ; Carta L; Jackson AM; Lemoine NR; Vassaux G
    Gene Ther; 2002 Nov; 9(21):1455-63. PubMed ID: 12378408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced in vivo gene expression mediated by listeriolysin O incorporated anionic LPDII: Its utility in cytotoxic T lymphocyte-inducing DNA vaccine.
    Sun X; Provoda C; Lee KD
    J Control Release; 2010 Dec; 148(2):219-25. PubMed ID: 20620181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors immortalized by HPV-16.
    Gunn GR; Zubair A; Peters C; Pan ZK; Wu TC; Paterson Y
    J Immunol; 2001 Dec; 167(11):6471-9. PubMed ID: 11714814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an Escherichia coli expressing listeriolysin-O vaccine against Wilms tumor gene 1-expressing tumors.
    Dai MS; Nitcheu-Tefit J; Alcock S; Ramirez-Jimenez F; Chao TY; Baril P; Rocha M; Brett SJ; Stauss HJ; Vassaux G
    J Immunother; 2009 Oct; 32(8):845-55. PubMed ID: 19752749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tc1 and Tc2 effector cell therapy elicit long-term tumor immunity by contrasting mechanisms that result in complementary endogenous type 1 antitumor responses.
    Dobrzanski MJ; Reome JB; Hollenbaugh JA; Dutton RW
    J Immunol; 2004 Feb; 172(3):1380-90. PubMed ID: 14734713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced priming of antigen-specific CTLs in vivo by embryonic stem cell-derived dendritic cells expressing chemokine along with antigenic protein: application to antitumor vaccination.
    Matsuyoshi H; Senju S; Hirata S; Yoshitake Y; Uemura Y; Nishimura Y
    J Immunol; 2004 Jan; 172(2):776-86. PubMed ID: 14707047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Episomal expression of truncated listeriolysin O in LmddA-LLO-E7 vaccine enhances antitumor efficacy by preferentially inducing expansions of CD4+FoxP3- and CD8+ T cells.
    Chen Z; Ozbun L; Chong N; Wallecha A; Berzofsky JA; Khleif SN
    Cancer Immunol Res; 2014 Sep; 2(9):911-22. PubMed ID: 24872025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Archaeosomes induce long-term CD8+ cytotoxic T cell response to entrapped soluble protein by the exogenous cytosolic pathway, in the absence of CD4+ T cell help.
    Krishnan L; Sad S; Patel GB; Sprott GD
    J Immunol; 2000 Nov; 165(9):5177-85. PubMed ID: 11046050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant E. coli efficiently delivers antigen and maturation signals to human dendritic cells: presentation of MART1 to CD8+ T cells.
    Radford KJ; Jackson AM; Wang JH; Vassaux G; Lemoine NR
    Int J Cancer; 2003 Jul; 105(6):811-9. PubMed ID: 12767067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a novel T cell-oriented vaccine using CTL/Th-hybrid epitope long peptide and biodegradable microparticles, against an intracellular bacterium.
    Tanaka K; Enomoto N; Uehara M; Furuhashi K; Sakurai S; Yasui H; Karayama M; Hozumi H; Suzuki Y; Fujisawa T; Inui N; Nakamura Y; Nagata T; Suda T
    Microbiol Immunol; 2020 Oct; 64(10):666-678. PubMed ID: 32786043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circumvention of regulatory CD4(+) T cell activity during cross-priming strongly enhances T cell-mediated immunity.
    Heit A; Gebhardt F; Lahl K; Neuenhahn M; Schmitz F; Anderl F; Wagner H; Sparwasser T; Busch DH; Kastenmüller K
    Eur J Immunol; 2008 Jun; 38(6):1585-97. PubMed ID: 18465771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of Chicken Egg Ovalbumin to Dendritic Cells by Listeriolysin O-Secreting Vegetative
    Roeske K; Stachowiak R; Jagielski T; Kamiński M; Bielecki J
    J Microbiol Biotechnol; 2018 Jan; 28(1):122-135. PubMed ID: 29361209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic immunization of mice against Listeria monocytogenes using plasmid DNA encoding listeriolysin O.
    Cornell KA; Bouwer HG; Hinrichs DJ; Barry RA
    J Immunol; 1999 Jul; 163(1):322-9. PubMed ID: 10384131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracytoplasmic delivery of listeriolysin O by a vaccinal strain of Bacillus anthracis induces CD8-mediated protection against Listeria monocytogenes.
    Sirard JC; Fayolle C; de Chastellier C; Mock M; Leclerc C; Berche P
    J Immunol; 1997 Nov; 159(9):4435-43. PubMed ID: 9379042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sticholysin II shows similar immunostimulatory properties to LLO stimulating dendritic cells and MHC-I restricted T cell responses of heterologous antigen.
    Del Valle A; Acosta-Rivero N; Laborde RJ; Cruz-Leal Y; Cabezas S; Luzardo MC; Alvarez C; Labrada M; Rodríguez A; Rodríguez GL; Raymond J; Nogueira CV; Grubaugh D; Fernández LE; Higgins D; Lanio ME
    Toxicon; 2021 Sep; 200():38-47. PubMed ID: 34237340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing the stimulation of CD8+ T cells during infection with intracellular bacteria promotes differentiation primarily into a central (CD62LhighCD44high) subset.
    van Faassen H; Saldanha M; Gilbertson D; Dudani R; Krishnan L; Sad S
    J Immunol; 2005 May; 174(9):5341-50. PubMed ID: 15843531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.